Hemianopsia Market
Hemianopsia Market Analysis by Homonymous Hemianopsia, Quadrantanopsia, and Bitemporal Hemianopsia from 2023 to 2033
Analysis of Hemianopsia Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Hemianopsia Market Outlook (2023 to 2033)
The global hemianopsia market is valued at US$ 333.9 million in 2023 and is projected to reach US$ 720.9 million by 2033. Global demand for hemianopsia treatment solutions is forecasted to increase rapidly at a CAGR of 8% between 2023 and 2033.
Hemianopsia, also known as hemianopia or hemiopia, is a condition where an individual loses half of their visual field in one or both eyes due to damage in the brain's visual processing areas. This condition can be caused due to various conditions, including stroke, traumatic brain injuries, brain tumours, and other neurological disorders.
- Around 2 billion people worldwide are living with some kind of vision disorder, according to WHO.
Hemianopsia is triggered by the central nervous system's disturbance of visual pathways. The rising prevalence of stroke and neurological disorders worldwide is boosting the demand for hemianopsia treatment solutions.
- According to the Global Stroke Factsheet published by the World Health Organization (WHO) in 2022, the lifetime risk of having a stroke has increased by fifty percent over the past 17 years, with an estimated 1 in 4 people experiencing a stroke.
Lesions can be categorised as prechiasmal, chiasmal, or retrochiasmal. Monocular blindness is brought on by prechiasmal lesions, which damage the optic nerve of the affected eye. Bitemporal hemianopsia is caused by optic chiasm lesions that impair the medial decussating nasal fibers. Optic radiations, the primary visual cortex, and the optic tract can all be affected by lesions posterior to the chiasm.
Homonymous hemianopsia is typically caused by injury to the optic tract and primary visual cortex, whereas damage to the optic radiations causes an inferior or superior quadrantanopia. Homonymous hemianopsia can be further classified into right homonymous hemianopsia and left homonymous hemianopsia.
Macular sparing, also known as homologous hemianopsia with preservation of the central visual field, is a sign that the main visual cortex, which receives a dual circulatory supply from the middle and posterior cerebral arteries, has been damaged.
Technologies referred to as ‘assistive’ are those that aim to make it easier for persons with vision disabilities and other challenges to live a comfortable and normal life. Due to an increase in trauma cases and traffic accidents, the number of people with disabilities has been rising quickly in recent years. Future sales of assistive devices for the visually impaired are expected to be greatly influenced by the increasing prevalence of vision impairment and blindness worldwide.
Report Attributes |
Details |
|
Hemianopsia Market Size (2023E) |
US$ 333.9 Million |
|
Forecasted Market Value (2033F) |
US$ 720.9 Million |
|
Global Market Growth Rate (2023 to 2033) |
8% CAGR |
|
Leading Regional Market |
North America |
|
Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What is Driving the Hemianopsia Treatment Market Forward?
“Hemianopsia - Untapped Market Ripe for Innovation and Disruption”
The hemianopsia market presents both opportunities and challenges for newcomers. On the one hand, there is a significant unmet need for effective treatments for this condition, which affects a large and growing patient population. As awareness of the condition increases, demand for treatments is likely to rise, creating a potentially lucrative market for new entrants.
However, there are also significant barriers to entry in this field. The high costs associated with developing and marketing advanced treatment solutions, as well as the need to navigate complex regulatory frameworks, can make it difficult for newcomers to establish a foothold.
There are several established market players, including pharmaceutical companies, medical device manufacturers, and others. These companies have significant resources and expertise in the field, making it challenging for newcomers to compete effectively.
To succeed in this field, new entrants will need to develop innovative, cost-effective treatments that address the unmet needs of patients and differentiate themselves from existing players. They will also need to build strong partnerships with healthcare providers and payers, as well as invest in robust marketing and educational campaigns to increase awareness of their products and services.
Overall, while the hemianopsia market offers significant opportunities for newcomers, it is a highly competitive and complex field that requires careful planning and execution to succeed.
“Culprits Behind Hemianopsia - Stroke, Head Injury, and More”
A stroke, a head injury, a mass occupying lesion, invasive surgery, or a neurologic disorder such as multiple sclerosis, Alzheimer's disease, or epilepsy can all cause homologous hemianopsia. Pituitary adenomas, craniopharyngiomas, and meningiomas are among the mass-occupying lesions that are commonly linked to bitemporal hemianopsia.
Bitemporal hemianopsia can also be brought on by vascular diseases such as anterior communicating artery aneurysms or basilar skull trauma. Thus, increasing cases of all such disorders creates a high risk of hemianopsia, which further is likely to boost the sales of hemianopsia treatment solutions during the forecast period.
Hemianopsia is a visual field defect that occurs as a result of stroke, specifically damage to the brain's visual processing areas. A stroke, which is a disruption of blood flow to the brain, can occur due to either an ischemic stroke, where a blood vessel becomes blocked and restricts blood flow, or a hemorrhagic stroke, where bleeding occurs in the brain.
- According to the Centers for Disease Control & Prevention, every 40 seconds one in the United States experiences a stroke.
- Globally, traumatic brain injury (TBI) is a leading cause of health problems and visual disability. According to studies by "uptodate," estimates of the annual incidence of TBI range from 27 to 69 million worldwide.
- According to a WHO report published in September 2022, over 55 million people worldwide suffer from dementia, with almost 10 million new cases being diagnosed each year. Alzheimer's condition is the most widespread type of dementia, accounting for 60% to 70% of the total number of cases of dementia, according to the WHO.
- According to the study ‘Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition’, which was released in December 2020. There are around 2.8 million cases of multiple sclerosis (MS) globally.
- Epilepsy is one of the most prevalent neurological diseases worldwide, with an estimated 50 million people suffering from it, according to the World Health Organization's February 2022 update.
“Hemianopsia Awareness on the Rise - Impact of Advanced Diagnostics on Public Health”
Development of advanced diagnostic technologies such as OCT (Optical Coherence Tomography), MRI (Magnetic Resonance Imaging), and CT (Computed Tomography) has greatly improved the diagnosis of hemianopsia. This has led to greater awareness and earlier detection of the condition, thereby boosting the growth of the market for hemianopsia.
“Virtual Reality, Prism Adaptation, and Visual Prostheses - Key Players Driving Hemianopsia Treatment to Next Level”
Key players in the hemianopsia market are taking major efforts on developing new technologies and treatment options for hemianopsia, such as virtual reality-based rehabilitation, prism adaptation therapy, and visual prostheses. These advancements are expected to generate potential opportunities in the hemianopsia market by increasing the availability of effective treatments.
“Small Incisions, Big Results Due to Minimally-Invasive Hemianopsia Treatment”
There is a growing preference for minimally-invasive treatment options, such as visual field restoration therapy, which has minimal side effects and faster recovery time compared to invasive surgeries. This is expected to drive the demand for non-invasive treatments for hemianopsia
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Which Aspects Should Manufacturers of Hemianopsia Treatment Solutions Focus More On?
“Delayed Treatment and Poorer Outcomes Resulting from Misdiagnosis”
One of the key challenges is limited awareness and understanding of the condition among patients and healthcare professionals in some regions. Hemianopsia is not well-known and often goes undiagnosed or misdiagnosed, which can lead to delayed treatment and poorer outcomes for patients. In addition, there is often a lack of awareness of the available treatment options, which can limit access for patients.
Limited availability of specialized treatment centers and healthcare professionals with expertise in hemianopsia in developing or poor regions further hampers sales of hemianopsia treatment solutions.
“High Overall Treatment Costs”
Another challenge is the high costs associated with diagnosis and treatment. Diagnostic tests such as MRI or CT scans can be expensive, and specialized treatment options such as visual field restoration therapy or visual prostheses may not be covered by insurance. This can make it difficult for some patients to access the care they need.
Country-wise Analysis
What is Influencing the Sales of Hemianopsia Treatment Solutions in the United States?
“Advanced Healthcare Facilities and Point-of-Care Services Driving Hemianopsia Treatment Solution Sales”
Advanced healthcare facilities, well-equipped hospitals, rising cases of strokes, and availability of point-of-care services are responsible for the maximum sales of hemianopsia treatment solutions in the United States. The significant demand for hemianopsia products is caused by a large patient population and ease of accessing advanced treatment.
- More than 795,000 Americans experienced strokes in 2021, according to data released by the Centers for Disease Control and Prevention (CDC) in April 2022.
What is the Demand Outlook for Hemianopsia Treatment in Japan?
“Supportive Healthcare Initiatives Catalyst for Hemianopsia Treatment Technology Sales Growth”
Japan is a highly profitable marketplace for producers of hemianopsia technologies, as more than 30% of Japan’s population is 60 or older. There is a high prevalence rate of eye disorders among the older population. In Japan, demand for advanced hemianopsia treatment options such as low-vision assistive devices and visual prostheses is expected to expand over the next 10 years as the country's ageing population grows.
During the next ten years, it is anticipated that the introduction of supportive government healthcare initiatives to enhance the quality of life for the elderly in Japan would have a significant influence on the sales of hemianopsia treatment technologies.
How is Demand for Hemianopsia Treatment Technologies Progressing in Germany?
“Germany's High Rate of Head Injuries & Skull Fractures Increasing Risk of Hemianopsia”
Germany is one of the leading marketplaces in the European region. This may be due to the presence of key market players and well-established healthcare facilities.
There is also a high rate of the elderly population and a prevalence of brain illnesses such as brain tumours, epilepsy, and stroke in the country. Therefore, each of these elements plays a big part in the growing demand for neurological monitoring equipment. Thus, the rising incidence of traumatic brain injuries increases the danger of hemianopsia, which further boosts demand for hemianopsia treatment devices.
- In April 2021, a paper in the journal Safety Science revealed that Germany has a high rate of head injuries and skull fractures.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Analysis
Why Do Hospitals Account for High Sales of Hemianopsia Treatment Solutions?
“Advanced Technologies & Skilled Workforce Attract Target Patients”
Hospitals are playing a crucial role in boosting the sales of hemianopsia treatment solutions. With the rising prevalence of stroke and other neurological disorders, there has been a significant surge in the demand for hemianopsia treatment devices and solutions. Hospitals, being the primary centers for the diagnosis and treatment of these conditions, are preferred as the first choice for treatment procedures by target patients.
Hospitals are investing heavily in the latest technologies and equipment to provide advanced treatment to their patients. They are adopting low-vision assistive devices, visual prostheses, and several other treatment devices. This has led to a significant increase in the sales of hemianopsia treatment devices and solutions.
In addition to providing advanced treatment, hospitals are also conducting awareness programs and educational campaigns to create awareness about hemianopsia and its treatment options.
Competitive Landscape
Leading companies in the hemianopsia market are investing heavily in research and development activities to come up with innovative and advanced hemianopsia treatment solutions. This gives them an edge in the market and boosts their revenue growth. They are also entering into partnerships and collaborations with hospitals, clinics, and other healthcare providers to increase their reach and boost sales.
Key Segments of Hemianopsia Industry Research
-
By Type :
- Homonymous Hemianopsia
- Quadrantanopsia
- Bitemporal Hemianopsia
-
By Treatment :
- Vision Restoration Therapy
- Visual Field Expander Aid
-
By End User :
- Hospitals
- Speciality Clinics
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
1. Global Market - Executive Summary 1.1. Global Market Overview 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Fact.MR Analysis and Recommendations 2. Global Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Introduction and Definition 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Hemianopsia 3.1.2. COVID-19 Crisis and Impact on Aprotic Solvent Prices 3.1.3. COVID-19 Impact Benchmark with Previous Crisis 3.1.3.1. Change in Demand 3.1.3.2. Before and After COVID-19 Crisis (Projected) 3.1.3.3. Before and After Sub-prime Crisis – 2008 (Actual) 3.1.3.4. Change in Demand post Recovery Period (After Each Crisis) 3.1.4. Impact on Market and Value (US$ Mn) 3.1.4.1. Likely Loss of Value in 2022 3.1.4.2. Mid-term and Long Term Forecast 3.1.4.3. Quarter by Quarter Demand and Recovery Assessment 3.1.5. Anticipated Demand and Value Recovery Curve 3.1.5.1. Likelihood of U-Shape Recovery 3.1.5.2. Likelihood of L-Shape Recovery 3.1.6. Recovery Period Assessment by Key Countries 3.1.7. Recovery Assessment by Key Market Segments 3.1.8. Action Points and Recommendations for Suppliers 3.1.9. Impact on Trade Balance 3.2. Key Trends Impacting the Market 3.3. Formulation and Source Development Trends 4. Market Background and foundation Data Points 4.1. Need of the Hour for Industries 4.2. Industry Wise Industry 4.0 4.3. Strategic Priorities 4.4. Life Cycle Stage 4.5. Importance of Technology 4.6. Use Cases of Hemianopsia 4.7. Forecast Factors: Relevance and Impact 4.8. Investment Feasibility Matrix 4.9. PESTLE Analysis 4.10. Porter’s Five Forces Analysis 4.11. Market Dynamics 4.11.1. Drivers 4.11.2. Restraints 4.11.3. Opportunity Analysis 4.11.4. Trend 5. Global Market Demand (US$ Mn) Analysis 2018 to 2022 and Forecast, 2023 to 2033 5.1. Historical Market Value (US$ Mn) Analysis, 2018 to 2022 5.2. Current and Future Market Value (US$ Mn) Projections, 2023 to 2033 5.2.1. Y-o-Y Growth Trend Analysis 5.2.2. Absolute $ Opportunity Analysis 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type 6.1. Introduction / Key Findings 6.2. Historical Market Value (US$ Mn) Analysis By Type, 2018 to 2022 6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Type, 2023 to 2033 6.3.1. Homonymous Hemianopsia 6.3.2. Quadrantanopsia 6.3.3. Bitemporal Hemianopsia 6.4. Market Attractiveness Analysis By Type 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Treatment 7.1. Introduction / Key Findings 7.2. Historical Market Value (US$ Mn) Analysis By Treatment , 2018 to 2022 7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Treatment, 2023 to 2033 7.3.1. Vision Restoration Therapy 7.3.2. Visual Field Expander Aid 7.4. Market Attractiveness Analysis By Treatment 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by End User 8.1. Introduction / Key Findings 8.2. Historical Market Value (US$ Mn) Analysis By End User, 2018 to 2022 8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By End User, 2023 to 2033 8.3.1. Hospitals 8.3.2. Speciality Clinics 8.4. Market Attractiveness Analysis By End User 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region 9.1. Introduction / Key Findings 9.2. Historical Market Value (US$ Mn) Analysis By Region, 2018 to 2022 9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. East Asia 9.3.5. South Asia & Oceania 9.3.6. Middle East and Africa (MEA) 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 10.1. Introduction / Key Findings 10.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 10.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033 10.3.1. By Country 10.3.1.1. United States 10.3.1.2. Canada 10.3.2. By Type 10.3.3. By Treatment 10.4. Market Attractiveness Analysis 10.4.1. By Country 10.4.2. By Type 10.4.3. By Treatment 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033 11.3.1. By Country 11.3.1.1. Brazil 11.3.1.2. Mexico 11.3.1.3. Rest of Latin America 11.3.2. By Type 11.3.3. By Treatment 11.3.4. By End User 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Type 11.4.3. By Treatment 11.4.4. By End User 12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033 12.3.1. By Country 12.3.1.1. Germany 12.3.1.2. France 12.3.1.3. Italy 12.3.1.4. Spain 12.3.1.5. United Kingdom 12.3.1.6. BENELUX 12.3.1.7. Russia 12.3.1.8. Rest of Europe 12.3.2. By Type 12.3.3. By Treatment 12.3.4. By End User 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Type 12.4.3. By Treatment 12.4.4. By End User 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033 13.3.1. By Country 13.3.1.1. China 13.3.1.2. Japan 13.3.1.3. South Korea 13.3.2. By Type 13.3.3. By Treatment 13.3.4. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Type 13.4.3. By Treatment 13.4.4. By End User 14. South Asia & Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033 14.3.1. By Country 14.3.1.1. India 14.3.1.2. Thailand 14.3.1.3. Malaysia 14.3.1.4. Singapore 14.3.1.5. Vietnam 14.3.1.6. ANZ 14.3.1.7. Rest of South Asia & Oceania 14.3.2. By Type 14.3.3. By Treatment 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Type 14.4.3. By Treatment 14.4.4. By End User 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033 15.3.1. By Country 15.3.1.1. GCC Countries 15.3.1.2. South Africa 15.3.1.3. Israel 15.3.1.4. Rest of Middle East and Africa (MEA) 15.3.2. By Type 15.3.3. By Treatment 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Type 15.4.3. By Treatment 15.4.4. By End User 16. Market Structure Analysis 16.1. Market Analysis by Tier of Companies 16.2. Market Concentration 16.3. Market Share Analysis of Top Players 16.4. Market Presence Analysis 17. Competition Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Competition Deep Dive 17.3.1. Vycor Medical, Inc. 17.3.1.1. Company Overview 17.3.1.2. Source overview 17.3.1.3. SWOT Analysis 17.3.1.4. Key Developments 17.3.2. RetroSense Therapeutics, LLC 17.3.2.1. Company Overview 17.3.2.2. Source overview 17.3.2.3. SWOT Analysis 17.3.2.4. Key Developments 17.3.3. Chadwick Optical 17.3.3.1. Company Overview 17.3.3.2. Source overview 17.3.3.3. SWOT Analysis 17.3.3.4. Key Developments 17.3.4. Healio 17.3.4.1. Company Overview 17.3.4.2. Source overview 17.3.4.3. SWOT Analysis 17.3.4.4. Key Developments 17.3.5. Carl Zeiss AG, 17.3.5.1. Company Overview 17.3.5.2. Source overview 17.3.5.3. SWOT Analysis 17.3.5.4. Key Developments 17.3.6. AbbVie Inc 17.3.6.1. Company Overview 17.3.6.2. Source overview 17.3.6.3. SWOT Analysis 17.3.6.4. Key Developments 17.3.7. Aerie Pharmaceuticals, Inc. 17.3.7.1. Company Overview 17.3.7.2. Source overview 17.3.7.3. SWOT Analysis 17.3.7.4. Key Developments 17.3.8. Novartis AG 17.3.8.1. Company Overview 17.3.8.2. Source overview 17.3.8.3. SWOT Analysis 17.3.8.4. Key Developments 17.3.9. AkzoNobel N.V. 17.3.9.1. Company Overview 17.3.9.2. Source overview 17.3.9.3. SWOT Analysis 17.3.9.4. Key Developments 17.3.10. F. Hoffmann-La Roche Ltd. 17.3.10.1. Company Overview 17.3.10.2. Source overview 17.3.10.3. SWOT Analysis 17.3.10.4. Key Developments 18. Assumptions And Acronyms Used 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 02: Global Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 04: Global Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 05: Global Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 07: Global Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 08: Global Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2018 to 2022
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2023 to 2033
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2023 to 2033
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 16: North America Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 17: North America Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 19: North America Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 20: North America Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 22: North America Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 23: North America Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 28: Latin America Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 29: Latin America Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 31: Latin America Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 32: Latin America Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 34: Latin America Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 35: Latin America Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 40: Europe Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 41: Europe Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 43: Europe Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 44: Europe Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 46: Europe Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 47: Europe Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 52: East Asia Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 53: East Asia Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 55: East Asia Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 56: East Asia Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 58: East Asia Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 59: East Asia Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 76: MEA Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 77: MEA Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 79: MEA Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 80: MEA Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 82: MEA Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 83: MEA Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 04: Global Market Incremental $ Opportunity, 2023 to 2033
Figure 05: Global Market Share and BPS Analysis by Type, 2023 & 2033
Figure 06: Global Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 07: Global Market Attractiveness Analysis by Type, 2023 to 2033
Figure 08: Global Market Share and BPS Analysis by Treatment, 2023 & 2033
Figure 09: Global Market Y-o-Y Growth Projections by Treatment, 2023 to 2033
Figure 10: Global Market Attractiveness Analysis by Treatment, 2023 to 2033
Figure 11: Global Market Share and BPS Analysis by End User, 2023 & 2033
Figure 12: Global Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 13: Global Market Attractiveness Analysis by End User, 2023 to 2033
Figure 14: Global Market Share and BPS Analysis by Region, 2023 & 2033
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2023 to 2033
Figure 16: Global Market Attractiveness Analysis by Region, 2023 to 2033
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2033
Figure 20: North America Market Incremental $ Opportunity, 2023 to 2033
Figure 21: North America Market Share Analysis by Country, 2023 & 2033
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 23: North America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 24: North America Market Share and BPS Analysis by Type, 2023 & 2033
Figure 25: North America Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 26: North America Market Attractiveness Analysis by Type, 2023 to 2033
Figure 27: North America Market Share and BPS Analysis by Treatment, 2023 & 2033
Figure 28: North America Market Y-o-Y Growth Projections by Treatment, 2023 to 2033
Figure 29: North America Market Attractiveness Analysis by Treatment, 2023 to 2033
Figure 30: North America Market Share and BPS Analysis by End User, 2023 & 2033
Figure 31: North America Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 32: North America Market Attractiveness Analysis by End User, 2023 to 2033
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 36: Latin America Market Incremental $ Opportunity, 2023 to 2033
Figure 37: Latin America Market Share Analysis by Country, 2023 & 2033
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 39: Latin America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 40: Latin America Market Share and BPS Analysis by Type, 2023 & 2033
Figure 41: Latin America Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 42: Latin America Market Attractiveness Analysis by Type, 2023 to 2033
Figure 43: Latin America Market Share and BPS Analysis by Treatment, 2023 & 2033
Figure 44: Latin America Market Y-o-Y Growth Projections by Treatment, 2023 to 2033
Figure 45: Latin America Market Attractiveness Analysis by Treatment, 2023 to 2033
Figure 46: Latin America Market Share and BPS Analysis by End User, 2023 & 2033
Figure 47: Latin America Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 48: Latin America Market Attractiveness Analysis by End User, 2023 to 2033
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 52: Europe Market Incremental $ Opportunity, 2023 to 2033
Figure 53: Europe Market Share Analysis by Country, 2023 & 2033
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 55: Europe Market Attractiveness Analysis by Country, 2023 to 2033
Figure 56: Europe Market Share and BPS Analysis by Type, 2023 & 2033
Figure 57: Europe Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 58: Europe Market Attractiveness Analysis by Type, 2023 to 2033
Figure 59: Europe Market Share and BPS Analysis by Treatment, 2023 & 2033
Figure 60: Europe Market Y-o-Y Growth Projections by Treatment, 2023 to 2033
Figure 61: Europe Market Attractiveness Analysis by Treatment, 2023 to 2033
Figure 62: Europe Market Share and BPS Analysis by End User, 2023 & 2033
Figure 63: Europe Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 64: Europe Market Attractiveness Analysis by End User, 2023 to 2033
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 68: East Asia Market Incremental $ Opportunity, 2023 to 2033
Figure 69: East Asia Market Share Analysis by Country, 2023 & 2033
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 71: East Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 72: East Asia Market Share and BPS Analysis by Type, 2023 & 2033
Figure 73: East Asia Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 74: East Asia Market Attractiveness Analysis by Type, 2023 to 2033
Figure 75: East Asia Market Share and BPS Analysis by Treatment, 2023 & 2033
Figure 76: East Asia Market Y-o-Y Growth Projections by Treatment, 2023 to 2033
Figure 77: East Asia Market Attractiveness Analysis by Treatment, 2023 to 2033
Figure 78: East Asia Market Share and BPS Analysis by End User, 2023 & 2033
Figure 79: East Asia Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 80: East Asia Market Attractiveness Analysis by End User, 2023 to 2033
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2023 to 2033
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2023 & 2033
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2023 to 2033
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Type, 2023 & 2033
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Type, 2023 to 2033
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Treatment, 2023 & 2033
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Treatment, 2023 to 2033
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Treatment, 2023 to 2033
Figure 94: South Asia & Oceania Market Share and BPS Analysis by End User, 2023 & 2033
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 96: South Asia & Oceania Market Attractiveness Analysis by End User, 2023 to 2033
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 100: MEA Market Incremental $ Opportunity, 2023 to 2033
Figure 101: MEA Market Share Analysis by Country, 2023 & 2033
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 103: MEA Market Attractiveness Analysis by Country, 2023 to 2033
Figure 104: MEA Market Share and BPS Analysis by Type, 2023 & 2033
Figure 105: MEA Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 106: MEA Market Attractiveness Analysis by Type, 2023 to 2033
Figure 107: MEA Market Share and BPS Analysis by Treatment, 2023 & 2033
Figure 108: MEA Market Y-o-Y Growth Projections by Treatment, 2023 to 2033
Figure 109: MEA Market Attractiveness Analysis by Treatment, 2023 to 2033
Figure 110: MEA Market Share and BPS Analysis by End User, 2023 & 2033
Figure 111: MEA Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 112: MEA Market Attractiveness Analysis by End User, 2023 to 2033
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the value of the hemianopsia market in 2023?
The global hemianopsia market is currently valued at US$ 333.9 million.
What is the projected market value for hemianopsia treatment products by 2033?
Sales of hemianopsia treatment solutions are expected to reach US$ 720.9 million by 2033.
At what rate is the hemianopsia market forecasted to expand during the forecast period?
Demand for hemianopsia treatment solutions is predicted to increase at a CAGR of 8% from 2023 to 2033.
Who are the leading market players in this space?
Vycor Medical, Inc., RetroSense Therapeutics, LLC, and Chadwick Optical are some of the leading companies in the market.
Which is the main factor driving the market for hemianopsia treatment solutions?
Increasing cases of brain injuries, stroke, and Alzheimer’s are driving market growth substantially.
Hemianopsia Market